European urology 2024 Jul 17
Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials.
Related Questions
For example, if a patient with intermediate risk prostate cancer has a high risk Decipher score (10 year risk of metastasis with standard therapy of &...
New comment by Radiation Oncologist at Texas Oncology-Arlington Cancer Center North ( October 6, 2025)
Thank you for this well-thought-out explanation.
Do you order predictive markers for all patients, including those with favorable intermediate risk? Would you give ADT if Art...